Calendrier des promotions Gland Pharma Limited
À propos de l'entreprise Gland Pharma Limited
Gland Pharma Limited, компания, специализирующаяся на инъекционных препаратах-дженериках, занимается разработкой, производством, продажей и распространением фармацевтических препаратов. Основные молекулы компании включают гепарин натрия, эноксапарин натрия, бромид рокурония и инъекции даптомицина, а также другие. plus de détailsParamètres de base
ISIN
INE068V01023
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
1.07
Дивиденд ао
20
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 5.39 | 2 |
| P/BV | 3.48 | 5 |
| P/E | 39.35 | 4 |
Efficacité
| Nom | Signification | Grade |
| ROA | 7.95 | 2 |
| ROE | 9.26 | 3 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 1.07 | 2.68 |
| DSI | 1 | 10 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | 0.2476 | 10 |
| Debt/Ratio | 0.0349 | 10 |
| Debt/Equity | 0.2221 | 10 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 119.37 | 10 |
| Rentabilité Ebitda, % | 39.46 | 5 |
| Rentabilité EPS, % | -0.9315 | 0 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 1 527.6 ₹ | 0 ₹ | 0 ₹ | 1.01 % | 0 % | 0 % |
| common.calendar.number_days.7d | 1 498.3 ₹ | 0 ₹ | 0 ₹ | 2.99 % | 0 % | 0 % |
| common.calendar.number_days.30d | 1 447.9 ₹ | 1 430.1 ₹ | 1 571.3 ₹ | 6.58 % | 0 % | 0 % |
| common.calendar.number_days.90d | 1 597.9 ₹ | 1 392.8 ₹ | 1 634 ₹ | -3.43 % | 0 % | 0 % |
| common.calendar.number_days.180d | 1 728.4 ₹ | 1 392.8 ₹ | 1 901.1 ₹ | -10.72 % | 0 % | 0 % |
| common.calendar.number_days.1y | 1 866.4 ₹ | 1 392.8 ₹ | 2 141.6 ₹ | -17.32 % | 0 % | 0 % |
| common.calendar.number_days.3y | 2 841.3 ₹ | 893.55 ₹ | 2 726.5 ₹ | -45.69 % | 0 % | 0 % |
| common.calendar.number_days.5y | 0 ₹ | 893.55 ₹ | 4 316.25 ₹ | 0 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 ₹ | 893.55 ₹ | 4 316.25 ₹ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 1 747.4 ₹ | 1 392.8 ₹ | 1 901.1 ₹ | -11.69 % | 0 % | 0 % |
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Mr. Srinivas Sadu | CEO & Executive Chairman | 123.58M | 1969 (56 années) |
| Mr. Ravi Shekhar Mitra | Chief Financial Officer | 15.15M | 1977 (48 années) |
| Mr. Sampath Kumar Pallerlamudi | Company Secretary & Vice-President of Compliance & CSR | 5.11M | 1981 (44 année) |
| Mr. Ankit Gupta | Head of Investments, Strategy & Investor Relations | N/A | |
| Mr. Satnam Singh Loomba | Chief Operating Officer | 1968 (57 années) | |
| Mr. Surinder Koul | Head of Domestic Marketing | ||
| Dr. Surapanini Sridevi | Senior Vice President of R&D | 1968 (57 années) | |
| Mr. K Raghuramachandra Rao | Head of Quality | ||
| Mr. Rong Wu | Chief Financial Controller |
Informations sur l'entreprise
Adresse: India, Hyderabad, Plot No. 11 & 84 TSIIC Phase: IV - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.glandpharma.com
Site web: https://www.glandpharma.com
